Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
MTX-531 is an EGFR antagonist and PI3K inhibitor.1 It selectively inhibits EGFR over HER2 and HER4 (IC50s = 14.7, 2,500, and >10,000 nM, respectively) and PI3Kδ, PI3Kα, and PI3Kγ over PI3Kβ (IC50s = 1.1, 6.4, 8.3, and 233 nM, respectively) but also inhibits DNA-dependent protein kinase (DNA-PK; IC50s = 5.4 nM). MTX-531 also induces gene expression in a reporter assay using HEK293 cells expressing PPARγ (EC50 = 3.4 µM). It decreases phosphorylated levels of Akt and 4E-BP1 and induces apoptosis in CAL-33 tongue squamous cell carcinoma cells when used at concentrations ranging from 3 to 10 µM. MTX-531 (100 mg/kg per day) reduces tumor volume and increases survival in a CAL-33 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. A first-